Biogen Idec Inc. (BIIB) was a big mover last session with shares rising over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company …
Al 11% RIF represents close to 880 employees among the more than 8,000 total workforce. Biogen stock is down 22% this year as Tecfidera sales have slowed down and the sector has slumped. The firm announced on Wednesday it will …
Shares of Biogen Inc closed the previous trading session at 276.57 down -3.41 -1.22% with 2,265,222 shares trading hands. The post Insider Trading Activity Biogen Inc (NASDAQ:BIIB) – VP Sold 9,892 shares of Stock appeared first …
exchanged or otherwise acquired the common stock of Biogen Idec, Inc., (Nasdaq:BIIB) between February 18, 2004 and …
NEW YORK--(BUSINESS WIRE)--The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or …
Biogen’s payment will include $625 million that will be used to purchase 11,501,153 shares of Ionis common stock at a price of $54.34 per share, a 19% premium to …
BIOGEN INC - BIOGEN WILL PAY IONIS $1 BILLION IN CASH, INCLUDING AN EQUITY INVESTMENT IN IONIS …
(Reuters) - Biogen Inc's second-quarter profit smashed estimates on Tuesday, boosted by strong sales of its spinal muscular atrophy (SMA) drug, Spinraza, which is priced at $750,000 for the first year of therapy. Buoyed by the …
Piven, P.A. today announced that a securities class action was commenced on behalf of shareholders who purchased, …
Jan 25 (Reuters) - Biogen Inc ::BIOGEN REPORTS RECORD REVENUES FOR BOTH THE FULL YEAR AND FOURTH QUARTER OF 2017, $12.3 BILLION AND $3.3 BILLION, RESPECTIVELY.2018 FULL YEAR REVENUE GUIDANCE …